GlassScriptPhysician profile
Erin E Dougher
NPI 1225328636
$15,419.48
in general payments reported to CMS, 2019-2025
20 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,822 · 2020: $677 · 2021: $5,179 · 2022: $4,666 · 2023: $1,501 · 2024: $1,411 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,690 · Honoraria: $745 · Travel and Lodging: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,690.30 |
| Honoraria | $744.96 |
| Travel and Lodging | $641.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $5,064.89 | 2022-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $4,732.15 | 2021 | |
| Boston Scientific Corporation | $1,370.80 | 2019-2024 | Solyx Sis System |
| Coloplast Corp | $1,135.14 | 2019-2025 | Saffron |
| Valencia Technologies Corporation | $558.14 | 2022 | |
| Medtronic, INC. | $436.99 | 2021-2022 | |
| Medtronic USA, INC. | $407.47 | 2019-2020 | |
| Caldera Medical, INC | $372.38 | 2019-2025 | |
| Abbvie INC. | $321.93 | 2019-2025 | Botox |
| Astellas Pharma US INC | $296.47 | 2019-2022 | |
| 180 Medical, INC. | $190.20 | 2022-2024 | Cure Catheter, Gentlecath Glide, Cure Ultra Catheter |
| Ethicon US, LLC | $156.29 | 2019 | |
| Coopersurgical, INC. | $101.96 | 2019 | |
| Sumitomo Pharma America, INC. | $96.19 | 2023-2025 | Gemtesa |
| Conmed Corporation | $58.31 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $35.34 | 2019-2021 | |
| Urogen Pharma, INC. | $23.22 | 2025 | |
| Teleflex LLC | $22.46 | 2025 | Urolift |
| Urovant Sciences INC | $21.65 | 2022 | |
| Laborie Medical Technologies Corp. | $17.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Dougher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.